← Leaderboards
Simon Haroutounian
Washington University
$3,884,023
Attributed
$8,791,462
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.2M · FY2018–24$10M$7.5M$5M$2.5M$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$8,791,462 · 4
By mechanism
RM1$4,618,885 · 1
R01$2,181,784 · 1
R61$1,587,553 · 1
R41$403,240 · 1
Top collaborators
- Meaghan C Creed1 shared
- Bahaa Elgendy1 shared
- Lamees Hegazy1 shared
- Chenyang Lu1 shared
- Thomas L Rodebaugh1 shared
- Andrew John Shepherd1 shared
- Pratik Sinha1 shared
Most similar at Washington University
Same institution · by research overlap
- Kelly R Monk$11,142,470
- Matthew D. Wood$1,839,228
- Thomas L Rodebaugh$2,414,750
- Valeria Cavalli$16,447,798
- Mikhail Y. Berezin$5,444,004
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectOpioidPharmaceutical PreparationsQuality Of LifePainAnalgesicsPain ModelMechanicsClinical TrialsAnimal ModelValidationImpairmentHypersensitivityPre-ClinicalPreventClinically RelevantPainful NeuropathyCerebrospinal FluidOverexpressionNerve InjuryBrainNon-Opioid AnalgesicAnimalsMediating
Grant awards (8)
IMPETUS: Integrated Mechanisms, Phenotypes, and Translational Underpinnings of Chronic Pain after Surgery$4,618,885
RM1 · FY2024 · NS · contact PI
Development of CNS-Active 5-HT3R Antagonists for the Treatment of Neuropathic Pain$1,587,553
R61 · FY2024 · NS
Clinical biomarker for early prediction of chemotherapy-induced peripheral neuropathy$403,240
R41 · FY2023 · CA · contact PI
5-HT3 receptor antagonists for neuropathic pain$423,145
R01 · FY2022 · NS · contact PI
5-HT3 receptor antagonists for neuropathic pain$429,937
R01 · FY2021 · NS · contact PI
5-HT3 receptor antagonists for neuropathic pain$437,180
R01 · FY2020 · NS · contact PI
5-HT3 receptor antagonists for neuropathic pain$439,604
R01 · FY2019 · NS · contact PI
5-HT3 receptor antagonists for neuropathic pain$451,918
R01 · FY2018 · NS · contact PI